Characterization of a Perfusion Reactor Utilizing Mammalian Cells on Microcarrier Beads

Our overall objective is to develop a cell culture analogue bioreactor (CCA) that can be used together with a corresponding physiologically based pharmacokinetic model (PBPK) to evaluate molecular mechanisms of toxicity. The PBPK is a mathematical model that divides the body into compartments representing organs, integrating the kinetic, thermodynamic, and anatomical parameters of the animal. The CCA bioreactor is a physical replica of the PBPK; where the PBPK specifies organs, the CCA bioreactor contains compartments with a corresponding cell type that mimics some of the characteristic metabolism of that organ. The device is a continuous, dynamic system composed of multiple cell types that interact through a common circulating cell culture medium. The CCA bioreactor and the model can be coupled to evaluate the plausibility of the molecular mechanism that is input into the model. This paper focuses on the design, development, and characterization of a CCA bioreactor to be used in naphthalene dose response studies. A CCA bioreactor prototype developed previously is improved upon by culturing the cells on microcarrier beads. Microcarrier beads with cells attached can form packed beds with cell culture medium perfusing the beds. In this study, two packed beds of cells, one with L2 cells (rat lung) and one with H4IIE cells (rat hepatoma), are linked in a physiologically relevant arrangement by a common recirculating cell culture medium. Studies of this CCA bioreactor presented here include mixing profiles, effect of reactor environment on cell viability and intracellular glutathione, naphthalene distribution profile, and initial naphthalene dosing studies. Unlike the prototype system there is no detectable response to naphthalene addition; in a companion paper we show that this discrepancy can be explained by differences in liquid residence times in the organ compartments. The perfusion reactor design is shown to have significant operating improvements over prototype designs.

[1]  M L Shuler,et al.  Use of In Vitro Data for Construction of a Physiologically Based Pharmacokinetic Model for Naphthalene in Rats and Mice To Probe Species Differences , 1999, Biotechnology progress.

[2]  F. Barile,et al.  In vitro cytotoxicity testing: Biological and statistical significance. , 1993, Toxicology in vitro : an international journal published in association with BIBRA.

[3]  Hans Rudolf Gnägi,et al.  CORRELATED MORPHOMETRIC AND BIOCHEMICAL STUDIES ON THE LIVER CELL , 1969, The Journal of cell biology.

[4]  W. Calder.  Size, Function, and Life History , 1988 .

[5]  N. Kalogerakis,et al.  Development of the optimal inoculation conditions for microcarrier cultures , 1992, Biotechnology and bioengineering.

[6]  J. A. Bond,et al.  Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice. , 1992, Carcinogenesis.

[7]  L M Sweeney,et al.  A cell culture analogue of rodent physiology: Application to naphthalene toxicology. , 1995, Toxicology in vitro : an international journal published in association with BIBRA.

[8]  J. Lechner,et al.  A serum-free method for culturing normal human bronchial epithelial cells at clonal density , 1985 .

[9]  E. Bresnick,et al.  Induction of cytochrome P450IA1 and its recombinant construct in H4IIE rat hepatoma cells. , 1993, The International journal of biochemistry.

[10]  J. A. Bond,et al.  In vivo metabolism of butadiene by mice and rats: a comparison of physiological model predictions and experimental data. , 1994, Carcinogenesis.

[11]  M L Shuler,et al.  Combining Cell Culture Analogue Reactor Designs and PBPK Models to Probe Mechanisms of Naphthalene Toxicity , 2000, Biotechnology progress.

[12]  F. Wiebel,et al.  Differential effects of 12-O-tetradecanoylphorbol 13-acetate on cytochrome P-450-dependent monooxygenase activities in rat hepatoma cells: induction of P-450I and suppression of P-450II. , 1990, Toxicology.

[13]  M L Shuler,et al.  A self-regulating cell culture analog device to mimic animal and human toxicological responses. , 1996, Biotechnology and bioengineering.

[14]  A. Fishman,et al.  Chromatographic demonstration of reversible changes in endothelial permeability. , 1989, Journal of applied physiology.

[15]  J. Sedlák,et al.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. , 1968, Analytical biochemistry.

[16]  D. Jenssen,et al.  Studies on glutathione transferases belonging to class pi in cell lines with different capacities for conjugating (+)-7β,8α-dihydroxy-9α, l0α-oxy-7,8,9,10-tetrahy drobenzo[a] pyrene , 1992 .

[17]  S. Hesse,et al.  Involvement of phenolic metabolites in the irreversible protein-binding of aromatic hydrocarbons: reactive metabolites of [14C]naphthalene and [14C]1-naphthol formed by rat liver microsomes. , 1979, Molecular pharmacology.

[18]  荒井保明.  Pharmacokinetics , 1993 .

[19]  J. Crapo,et al.  Tolerance and cross-tolerance using NO2 and O2 II. Pulmonary morphology and morphometry. , 1978, Journal of applied physiology: respiratory, environmental and exercise physiology.

[20]  E. Adolph,et al.  Quantitative Relations in the Physiological Constitutions of Mammals. , 1949, Science.

[21]  M E Andersen,et al.  Modeling receptor-mediated processes with dioxin: implications for pharmacokinetics and risk assessment. , 1993, Risk analysis : an official publication of the Society for Risk Analysis.

[22]  J. Giesy,et al.  Characterization of the H4IIE rat hepatoma cell bioassay as a tool for assessing toxic potency of planar halogenated hydrocarbons in environmental samples , 1991 .